Aggressive Anticoagulation May Decrease Mortality in Obese Critically Ill COVID-19 Patients

BACKGROUND: Obesity is a widely accepted risk factor for the development of severe COVID-19. We sought to determine the survival benefit of early initiation of aggressive anticoagulation in obese critically ill COVID-19 patients. METHODS: We retrospectively reviewed 237 intubated patients at a singl...

Descripción completa

Detalles Bibliográficos
Autores principales: Drakos, Panagiotis, Volteas, Panagiotis, Naeem, Zaina, Asencio, Anthony A., Cleri, Nathaniel A., Alkadaa, Leor N., Oganov, Anthony, Gammel, Theresa, Saadon, Jordan R., Bannazadeh, Mohsen, Tassiopoulos, Apostolos K., Mikell, Charles B., Rubano, Jerry, Pryor, Aurora, Spaniolas, Konstantinos, Mofakham, Sima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610786/
https://www.ncbi.nlm.nih.gov/pubmed/34816357
http://dx.doi.org/10.1007/s11695-021-05799-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610786/
https://www.ncbi.nlm.nih.gov/pubmed/34816357
http://dx.doi.org/10.1007/s11695-021-05799-8

Ejemplares similares